These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19303027)

  • 21. Characterization of pharmaceutically relevant materials at the solid state employing chemometrics methods.
    Calvo NL; Maggio RM; Kaufman TS
    J Pharm Biomed Anal; 2018 Jan; 147():538-564. PubMed ID: 28666554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
    Soares FL; Carneiro RL
    J Pharm Biomed Anal; 2014 Feb; 89():166-75. PubMed ID: 24291798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure and surface properties of an investigational drug--a case study.
    Kiang YH; Shi HG; Mathre DJ; Xu W; Zhang D; Panmai S
    Int J Pharm; 2004 Aug; 280(1-2):17-26. PubMed ID: 15265543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High-throughput crystallization in pharmaceutical research and development].
    Feng ZQ; Deng W; Guo ZR
    Yao Xue Xue Bao; 2005 Jun; 40(6):481-5. PubMed ID: 16144309
    [No Abstract]   [Full Text] [Related]  

  • 25. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
    Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
    Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-Ray Crystallographic Studies of G-Quadruplex Structures.
    Parkinson GN; Collie GW
    Methods Mol Biol; 2019; 2035():131-155. PubMed ID: 31444748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-ray crystallographic structures as a source of ligand alignment in 3D-QSAR.
    Urniaż RD; Jóźwiak K
    J Chem Inf Model; 2013 Jun; 53(6):1406-14. PubMed ID: 23705769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of protein crystals for X-ray structural study.
    Takeda S
    Methods Mol Med; 2006; 129():291-303. PubMed ID: 17085819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design.
    Moore J; Abdul-Manan N; Fejzo J; Jacobs M; Lepre C; Peng J; Xie X
    J Synchrotron Radiat; 2004 Jan; 11(Pt 1):97-100. PubMed ID: 14646145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The advantages and limitations of protein crystal structures.
    Acharya KR; Lloyd MD
    Trends Pharmacol Sci; 2005 Jan; 26(1):10-4. PubMed ID: 15629199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Industrial perspective on X-ray data collection and analysis.
    Skarzynski T; Thorpe J
    Acta Crystallogr D Biol Crystallogr; 2006 Jan; 62(Pt 1):102-7. PubMed ID: 16369099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Life in the fast lane for protein crystallization and X-ray crystallography.
    Pusey ML; Liu ZJ; Tempel W; Praissman J; Lin D; Wang BC; Gavira JA; Ng JD
    Prog Biophys Mol Biol; 2005 Jul; 88(3):359-86. PubMed ID: 15652250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic products in coordination networks: ab initio X-ray powder diffraction analysis.
    Martí-Rujas J; Kawano M
    Acc Chem Res; 2013 Feb; 46(2):493-505. PubMed ID: 23252592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The computational prediction of pharmaceutical crystal structures and polymorphism.
    Price SL
    Adv Drug Deliv Rev; 2004 Feb; 56(3):301-19. PubMed ID: 14962583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and crystallization of RNA.
    Golden BL
    Methods Mol Biol; 2007; 363():239-57. PubMed ID: 17272845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput crystallography for structural genomics.
    Joachimiak A
    Curr Opin Struct Biol; 2009 Oct; 19(5):573-84. PubMed ID: 19765976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergy within structural biology of single crystal optical spectroscopy and X-ray crystallography.
    De la Mora-Rey T; Wilmot CM
    Curr Opin Struct Biol; 2007 Oct; 17(5):580-6. PubMed ID: 17959373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A medicinal chemistry perspective on structure-based drug design and development.
    Maddaford SP
    Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances in the quantitative analytical methods of drug polymorphism].
    Ma LW; Du W; Zhao CS
    Yao Xue Xue Bao; 2011 Aug; 46(8):896-903. PubMed ID: 22007512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.